Search

Author/Creator Bauerfeind, I.

3. German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients. (28th April 2017)

Authors:
Möbus, V.; von Minckwitz, G.; Jackisch, C.; Lück, H.-J.; Schneeweiss, A.; Tesch, H.; Elling, D.; Harbeck, N.; Conrad, B.; Fehm, T.; Huober, J.; Müller, V.; Bauerfeind, I.; du Bois, A.; Loibl, S.; Nekljudova, V.; Untch, M.; Thomssen, C.
Journal:
Annals of oncology
Issue:
Volume 28:Number 8(2017)
Page Start:
1803
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. The West German Study Group Breast Cancer Intrinsic Subtype study: a prospective multicenter decision impact study utilizing the Prosigna assay for adjuvant treatment decision-making in estrogen-receptor-positive, HER2-negative early-stage breast cancer. (2nd July 2016)

Authors:
Wuerstlein, R.; Sotlar, K.; Gluz, O.; Otremba, B.; von Schumann, R.; Witzel, I.; Schindlbeck, C.; Janni, W.; Schem, C.; Bauerfeind, I.; Hasmueller, S.; Tesch, H.; Paulenz, A.; Ghali, N.; Orujov, E.; Kates, R. E.; Cowens, W.; Hornberger, J.; Pelz, E.; Harbeck, N.
Journal:
Current medical research and opinion
Issue:
Volume 32:Number 7(2016:Jul.)
Page Start:
1217
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗